Hamps Bio Limited is coming up with an IPO with a fresh issue of 12,20,000 shares worth INR 6.22 crores. The company aims to purchase machinery, enhance brand visibility, and address general corporate needs.
Hamps Bio IPO – Important Dates
| Hamps Bio Limited IPO Date | December 13, 2024 to December 17, 2024 |
| Hamps Bio Limited IPO Listing Date | December 20, 2024 |
| Hamps Bio Limited IPO Price | INR 51 per share |
| Hamps Bio Limited IPO Lot Size | 2000 Shares |
| Hamps Bio Limited IPO Total Issue Size | INR 6.22 crores |
| Hamps Bio Limited IPO Basis of Allotment | December 18, 2024 |
| Hamps Bio Limited IPO Initiation of Refunds | December 19, 2024 |
| Hamps Bio Limited IPO Credit of Shares to Demat | December 19, 2024 |
| Hamps Bio Limited IPO Issue Type | Book Built Issue IPO |
| Hamps Bio Limited IPO Listing At | BSE SME |
Hamps Bio Limited IPO – Company Profile
Hamps Bio Limited markets and distributes pharmaceutical formulations under “Hamps” and freeze-dried FMCG products under “FzyEzy. ” It sells 180+ products via 50 distributors and e-commerce platforms across 8 Indian states and six countries.
With a robust sales network, Hamps Bio Limited reaches 8,000 doctors and medical stores monthly, offering 100+ pharmaceutical products under 32 brands across Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh through 30+ sales representatives.
With in-house manufacturing in Ankleshwar, Gujarat, the company produces certified freeze-dried products. It serves B2B industries and is expanding its B2C footprint nationwide and globally through e-commerce platforms and a strong distribution network.
Hamps Bio Ltd IPO Fundamental Analysis
Hamps Bio Limited’s financial analysis reveals a mixed performance. Revenue has shown steady growth, with improved profitability, higher EPS, and increased assets. However, RoNW decreased, and liquidity strength poses challenges for short-term obligations.
- Revenue Trend: The revenue increased from ₹534.05 lakhs in March 2022 to ₹557.81 lakhs in March 2023. The revenue for the current year’s 7-month period ending October 2024 is INR 426.67 lakhs.
- Equity and Liabilities: Equity has shown a consistent increase over the periods, reflecting potential growth and expansion. However, the debt-equity ratio has decreased, indicating reduced reliance on debt financing.
- Profitability: The profit after tax (PAT) has significantly increased from ₹12.15 lakhs in March 2022 to ₹34.08 lakhs by October 2024. This improvement in profitability could be a source of confidence among investors.
- Earnings per Share (EPS): The diluted EPS has risen from ₹0.51 in March 2022 to ₹1.09 by October 2024, reflecting higher earnings per share for investors.
- Return on Net Worth (RoNW): The RoNW has reduced from 12.08% to 9.19%, indicating a decrease in the company’s ability to generate returns on shareholder equity.
- Financial Position: Total assets have increased, suggesting potential business growth. However, the current ratio has increased, indicating strengthening liquidity and potential challenges in meeting short-term obligations.
- Inventory Turnover Ratio: There’s a significant increase in the Inventory Turnover Ratio, which might suggest faster sales or efficient inventory management.
Hamps Bio IPO Financial Analysis
| Particular | As of 31 March 2022 | As of 31 March 2023 | As of 31 October 2024 |
| Revenue (₹ in lakhs) | 534.05 | 557.81 | 426.67 |
| Equity (₹ in lakhs) | 100.57 | 136.30 | 370.78 |
| Expenses (₹ in lakhs) | 523.98 | 522.78 | 390.23 |
| Profit and Loss After Tax (₹ in lakhs) | 12.15 | 35.90 | 34.08 |
| Diluted EPS only (₹) | 0.51 | 1.50 | 1.09 |
| Return on Net Worth (%) | 12.08 | 26.34 | 9.19 |
| NAV per Equity Share (₹) | 6.70 | 9.09 | 11.82 |
| Total Assets (in lakhs) | 364.31 | 395.87 | 644.00 |
| Total Liabilities (in lakhs) | 263.74 | 259.57 | 273.22 |
| Debt Equity Ratio | 2.03 | 1.27 | 0.37 |
| Current Ratio (in times) | 0.74 | 0.59 | 1.38 |
| Inventory Turnover Ratio (in days) | 85.17 | 73.65 | 158.83 |
Hamps Bio Limited IPO Peer Comparison
There are no comparable listed companies in India for Hamps Bio Limited’s diverse business segments. However, peer companies include Mono Pharmacare Limited, Chandra Bhagat Pharma Limited for Pharma, and Flex Foods Limited for FMCG-FDFP.
Hamps Bio Ltd IPO Objective
The main objective of Hamps Bio Limited is to purchase plant and machinery for its FMCG division and enhance the visibility and awareness of its brand.
- Purchase of plant and machinery for FMCG division: The company intends to use INR 3.59 Crores from the Net Proceeds of the Fresh Issue to purchase new machinery to improve product quality, efficiency, and competitiveness, meet growing demand, and enhance business operations.
- Enhancing the visibility and awareness of their brand: The company plans to utilize INR 0.50 Crores from the Net Proceeds for marketing and promotional activities, including digital marketing, business promotion, and medical representative expenses, to increase brand visibility and customer acquisition in FY 2025 and 2026.
- General Corporate Purpose: The company will deploy INR 1.52 for general corporate purposes, including initial development costs for new products, meeting operating expenses and working capital requirements, and addressing unforeseen exigencies in the ordinary course of business.
Hamps Bio IPO Risks And Challenges
Hamps Bio Limited’s risk includes exposure to supply disruptions due to the absence of long-term agreements with manufacturers, operational delays from facility issues, and regulatory non-compliance, which could harm financial performance and reputation.
- The absence of long-term agreements with contract manufacturers poses a risk by exposing the company to supply disruptions or quality issues. This can lead to operational delays and product shortages and negatively impact financial performance.
- Disruptions at the manufacturing facility, such as equipment failure, power loss, or external factors like natural disasters or workforce issues, could hinder production, delay orders, harm the company’s reputation, and negatively affect financial results.
- Non-compliance with evolving pharmaceutical and FMCG regulations, including failure to renew necessary permits or meet safety standards, could result in fines, legal actions, or operational disruptions, negatively impacting the company’s financial health and reputation.
Hamps Bio Ltd IPO – Industry & Market Potential
India’s pharmaceutical industry is growing rapidly, projected to reach USD 65 billion by 2024 and USD 130 billion by 2030. It is a global leader in generics, APIs, biosimilars, and medical devices, with strong export growth.
India’s FMCG market reached USD 167 billion in 2023 and is expected to grow at a CAGR of 27.9% to USD 615.87 billion by 2027. Rural demand recovery, e-commerce growth, and government schemes fuel expansion.
Rural consumption is rising due to higher incomes and aspirations, with increased demand for branded products. E-commerce, youth population growth, and GST implementation are expected to drive FMCG sector growth in both urban and rural areas.
Hamps Bio Limited IPO – Type of Offer
Hamps Bio Limited is coming up with an IPO with a fresh issue of 12,20,000 shares worth INR 6.22 crores. The company aims to purchase machinery, enhance brand visibility, and address general corporate needs.
Hamps Bio IPO Offer Size
The offer size of Hamps Bio Limited is INR 6.22 crores, consisting of a fresh issue of 12,20,000 shares. The company aims to purchase machinery, enhance brand visibility, and address general corporate needs.
Hamps Bio Limited IPO Allotment Structure
Hamps Bio Limited’s Limited’s IPO allotment structure includes a category for Retail Individual Investors (RII) with investments below ₹2 lakhs, a category for other investors exceeding ₹2 lakhs, and a reservation of 62,000 shares for Market Makers.
- Retail Individual Investors (RII): These individual investors apply for shares with a total value of less than Rs.2,00,000.
- Other than retail individual investors: Such applications where the value exceeds INR 2,00,000.
- Market Makers Reservation: A certain percentage or number of shares is reserved for market makers. The company has set aside 62,000 shares for this purpose.
How to apply for Hamps Bio IPO?
To apply for the Hamps Bio Limited IPO through Alice Blue, follow these steps:
Open a Demat and Trading Account: If you don’t have one already, you must open a Demat and trading account with Alice Blue.
- Check for IPO Details: Once your account is active, you can check for the Hamps Bio Limited IPO details in the IPO section of the Alice Blue platform.
- Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
- Submit the Application: Confirm all your details and submit your application.
You can apply for the Hamps Bio Limited IPO at Alice Blue in just a few clicks!
Check Allotment Status: After the allotment process, you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How do you check Hamps Bio IPO Allotment Status?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
- Log in to your Alice Blue Account: You can do this through the Alice Blue website or the trading app.
- Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
- Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
- Select the Hamps Bio Limited IPO: If you have applied for multiple IPOs, there might be a dropdown menu or a list where you can select the IPO you are interested in. Select the Hamps Bio Limited IPO.
- Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, we request you to reach out to our customer support team at Alice Blue for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the Hamps Bio Limited IPO:
● Registrar’s Website: Visit the website of Bigshare Services Private Limited, the registrar of the Hamps Bio Limited IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN, application, or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
● BSE SME: You can also check the allotment status on the official websites of the Bombay Stock Exchange (BSE) Small Medium Exchange (SME). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after completing the allotment process, a few days after the IPO window closes.
Hamps Bio Ltd IPO Offer Registrar
The registrar for the Hamps Bio Limited IPO is Bigshare Services Private Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Pinnacle Business Park, Mahakali Caves Road, next toAhura Centre,
Andheri East, Mumbai – 400 093
Tel No: 022 – 6263 8200
Email: [email protected]
Website: www.bigshareonline.com
Hamps Bio SME IPO – FAQs
1. What is the allotment date of the Hamps Bio IPO?
The allotment date of the Hamps Bio is December 18, 2024.
2. What is the price band of the Hamps Bio IPO?
The price band of the issue is INR 51 per share.
3. What is the size of the Hamps Bio IPO?
The offer size of Hamps Bio Limited is INR 6.22 crores, consisting of a fresh issue of 12,20,000 shares. The company aims to purchase machinery, enhance brand visibility, and address general corporate needs.
4. What is the listing date of the Hamps Bio IPO?
The listing date of the Hamps Bio is December 20, 2024.
5. Where is the Hamps Bio IPO Getting Listed?
Hamps Bio is getting listed on the BomBaby Stock Exchange (BSE) and the Small Medium Exchange (SME).
6. What are the open and close dates of the Hamps Bio Limited IPO?
The open and close dates of the Hamps Bio Limited are December 13, 2024 and December 17, 2024.
7.How to apply for Hamps Bio Ltd IPO in Alice Blue?
To apply for the Hamps Bio Limited IPO via Alice Blue, open a Demat and Trading account, check IPO details, place your bid, submit the application, and check the allotment status. Allotment depends on demand and is not guaranteed.
8. Who is the Book Runner for the Hamps Bio IPO?
The Book Runner for the Hamps Bio is MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED.
